Congenital anomalies and resource utilization in neonates infected with herpes simplex virus

Sexually Transmitted Diseases

Volumn 36, Issue 11, 2009, Pages 680-685

  Ambroggio, Lilliam ^a   Lorch, Scott A ^b   Mohamad, Zeinab ^b,c   Mossey, Jana ^a   Shah, Samir S ^b,c  

^a DREXEL UNIVERSITY   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c Divisions of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ARTICLE; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; FEMALE; HEALTH CARE UTILIZATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HOSPITAL CHARGE; HOSPITALIZATION COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN INFECTION; NEWBORN MORTALITY;

ACYCLOVIR; ANTIVIRAL AGENTS; COHORT STUDIES; FEMALE; HEALTH RESOURCES; HEART DEFECTS, CONGENITAL; HERPES SIMPLEX; HOSPITAL CHARGES; HUMANS; INFANT; INFANT, NEWBORN; INFORMATION SYSTEMS; LENGTH OF STAY; MALE; PENNSYLVANIA; RETROSPECTIVE STUDIES; SIMPLEXVIRUS;

EID: 70350780526     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181aaf54f     Document Type: Article

References (18)

1. Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001; 108:230-238.
2. Kimberlin DW, Lin CY, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001; 108:223-229.
3. Rouse DJ, Stringer JS. An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes. Am J Obstet Gynecol 2000; 183:400-406.
4. Thung SF, Grobman WA. The cost-effectiveness of routine antenatal screening for maternal herpes simplex virus-1 and-2 antibodies. Am J Obstet Gynecol 2005; 192:483-488.
5. Baker D, Brown Z, Hollier LM, et al. Cost-effectiveness of herpes simplex virus type 2 serologic testing and antiviral therapy in pregnancy. Am J Obstet Gynecol 2004; 191:2074-2084. (Pubitemid 39601516)
6. ACOG practice bulletin. Management of herpes in pregnancy. Number 8 October 1999.
7. Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet 2000; 68:165-173.
8. Caviness AC, Demmler GJ, Swint JM, et al. Cost-effectiveness analysis of herpes simplex virus testing and treatment strategies in febrile neonates. Arch Pediatr Adolesc Med 2008; 162:665-674.
9. Keren R, Zaoutis TE, Bridges CB, et al. Neurological and neu-romuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA 2005; 294: 2188-2194.
10. Fixler DE. Respiratory syncytial virus infection in children with congenital heart disease: A review. Pediatr Cardiol 1996; 17:163-168.
11. MacDonald NE, Hall CB, Suffin SC, et al. Respiratory syncytial viral infection in infants with congenital heart disease. New Engl J Med 1982; 307:397-400.
12. Tao G, Kassler WJ, Rein DB. Medical care expenditures for genital herpes in the United States. Sex Transm Dis 2000; 27:32-38.
13. Gardner W, Mulvey EP, Shaw EC. Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models. Psychol Bull 1995; 118:392-404.
14. Concato J, Feinstein AR, Holford TR. The risk of determining risk with multivariable models. Ann Intern Med 1993; 118:201-210.
15. Brown ZA, Wald A, Morrow RA, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003; 289:203-209.
16. Kimberlin DW, Whitley RJ. Neonatal herpes: What have we learned. Semin Pediatr Infect Dis 2005; 16:7-16.
17. Donoval BA, Passaro DJ, Klausner JD. The public health imperative for a neonatal herpes simplex virus infection surveillance system. Sex Transm Dis 2006; 33:170-174.
18. Boneva RS, Botto LD, Moore CA, et al. Mortality associated with congenital heart defects in the United States: Trends and racial disparities, 1979-1997. Circulation 2001; 103:2376-2381.